Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-08

Clinical Trial Update: Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated the effect of Itopride on symptoms of functional dyspepsia (indigestion, bloating, early satiety). The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • itopride (itopride)

Snippet

Sponsor: Forest Laboratories | Conditions: Dyspepsia | Phase 3 | Status: COMPLETED